B-cell recovery after stem cell transplant
Part of Blood & lymphatic clinical trials.
This study looks at how the immune system rebuilds itself after a stem cell transplant. It may help doctors understand recovery better for people with blood cancers or other conditions needing a transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You are willing to take part in all parts of the study.
- You either have a plasma cell disease or lymphoma and are getting your own stem cells, OR you have a condition needing a donor stem cell transplant, OR you are a stem cell donor for someone in the study.
- You are able to sign a consent form and follow the study plan.
- You have not taken part in this study before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how your immune system “rebuilds” after certain cell-based cancer treatments or stem cell transplants. It may help researchers better understand why immune recovery differs between people and how to improve protection against infections.
This study looks at how a type of immune cell called gamma-delta T cells recovers in your body after a cord blood transplant. It may help doctors understand how to improve recovery and reduce complications.
This study uses a special score (immune risk score) to check how well your immune system rebuilds after a half-matched stem cell transplant. The goal is to find patients who might need extra help with immune recovery.
This trial checks how certain blood “biomarkers” change after you receive donor stem cells to rebuild your blood and immune system. The goal is to learn whether these markers can better predict your immune recovery after transplant.
This study looks at how the immune system recovers after a stem cell transplant for CMML (a type of blood cancer). It aims to understand patients' outcomes over time.
This trial tests whether adding back certain immune cells after a stem cell transplant can help prevent serious viral or fungal infections. It's for children and young adults up to age 25 who need a transplant for a blood cancer or other curable disease.
Hear when a new Stem Cell Transplantation, Hematopoietic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.